Results 171 to 180 of about 94,250 (267)
Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson. [PDF]
Lim JU +15 more
europepmc +1 more source
Barriers to publishing early phase clinical trials: the oncologists' perspective. [PDF]
Lucassen MJJ +23 more
europepmc +1 more source
A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers. [PDF]
Ahmed J +12 more
europepmc +1 more source
The Inflammatory Bridge Between Type 2 Diabetes and Neurodegeneration: A Molecular Perspective. [PDF]
Kacem H +5 more
europepmc +1 more source
Métodos para la determinación del mecanismo focal de los terremotos.
Elisa Buforn
openalex +2 more sources

